🌐 Wandercraft

About Wandercraft

Wandercraft was established in Paris in 2012 by engineers and medical professionals united by a shared goal: restoring independent walking to people with severe lower-limb paralysis. The company's first decade was devoted almost entirely to medical exoskeleton development, culminating in the Atalante X, a self-balancing, hands-free walking exoskeleton that allows users with complete spinal cord injury to walk without crutches or external support. This achievement set Wandercraft apart from competitors whose products still require the user to hold parallel bars or forearm crutches.

Having raised over $45 million from investors including Bpifrance, the company expanded its scope in the early 2020s to address the industrial robotics market with the Calvin platform, a full-size bipedal humanoid designed for factory and logistics environments. Calvin draws on the balance and gait technology developed for Atalante, applying the same self-stabilising algorithms to a general-purpose industrial body. This dual-track strategy, medical rehabilitation and industrial humanoids, positions Wandercraft as one of the few companies with proven clinical walking technology transferable to the commercial sector.

Key Products

• Atalante X: hands-free self-balancing walking exoskeleton for complete spinal cord injury rehabilitation; CE marked for clinical use
• Calvin: full-size bipedal industrial humanoid leveraging Atalante gait technology, targeting warehouse and factory deployments

UK Market Presence

Atalante X is available in the UK through rehabilitation hospitals and specialist clinical distributors. Several NHS-affiliated spinal injury centres have evaluated or deployed the system. The Calvin industrial platform was still in commercial development as of 2025; UK industrial customers interested in early access should contact Wandercraft directly. Pricing for Atalante X is negotiated at institutional level, typically via capital equipment budgets or leasing arrangements.

Buying Used Wandercraft Equipment

The secondhand market for Atalante exoskeletons is extremely limited, as most units remain in clinical settings under service contracts. Occasionally a unit becomes available when a rehabilitation centre upgrades or closes. Prices on the used market typically fall in the £60,000 to £120,000 range, reflecting the device's regulatory status and the ongoing software subscription required for clinical firmware updates. Prospective buyers must verify CE marking validity, confirm the unit has not exceeded its recommended service hours, and engage Wandercraft's clinical team to arrange refurbishment and continued software support before deployment.